A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Clinical trial NCT02655016 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02655016
- Sponsor
- Tesaro, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2019-05-17
- Enrollment
- 733
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.